Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

2.9K
The pathophysiology of pneumonia involves the following steps:
2.9K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

3.6K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.6K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

944
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
944
Pathophysiology of Vomiting01:22

Pathophysiology of Vomiting

3.0K
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
3.0K
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

1.3K
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.3K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

929
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
929

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Letter: Assessing Pruritus Efficacy With Peroxisome Proliferator-Activated Receptor Agonists in Primary Biliary Cholangitis Must Include Grading the Strength of Trial Evidence.

Alimentary pharmacology & therapeutics·2026
Same author

Can we cure primary biliary cholangitis?

Current opinion in immunology·2026
Same author

Reply: Fracture risk under selective and non-selective PPAR agonists in primary biliary cholangitis.

Hepatology communications·2026
Same author

Seladelpar Improved Itch, Itch-Related Sleep Disturbance and Measures of Fatigue in Patients With Primary Biliary Cholangitis and Pruritus in the Phase 3 RESPONSE Trial.

Alimentary pharmacology & therapeutics·2026
Same author

Primary Biliary Cholangitis and Prognostic Models-Reply.

JAMA·2026
Same author

The ethics of unlicensed therapy use in primary biliary cholangitis: a counter view.

Nature reviews. Gastroenterology & hepatology·2026

Related Experiment Video

Updated: Feb 3, 2026

Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction
07:44

Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction

Published on: March 25, 2022

6.8K

Pathophysiology of primary biliary cholangitis.

Aliya F Gulamhusein1, Gideon M Hirschfield2

  • 1Toronto Centre for Liver Disease, 200 Elizabeth Street, Toronto, ON, Canada.

Best Practice & Research. Clinical Gastroenterology
|October 23, 2018
PubMed
Summary

Primary biliary cholangitis involves immune attacks on bile duct cells, driven by anti-mitochondrial antibodies. Understanding its complex pathogenesis, including genetic and epigenetic factors, is key to developing new therapies for this autoimmune liver disease.

Keywords:
ApoptosisAutoimmunityCholangiocyteImmunology

More Related Videos

Hepatocyte-specific Ablation in Zebrafish to Study Biliary-driven Liver Regeneration
08:14

Hepatocyte-specific Ablation in Zebrafish to Study Biliary-driven Liver Regeneration

Published on: May 20, 2015

9.1K
Using a Whole-mount Immunohistochemical Method to Study the Innervation of the Biliary Tract in Suncus murinus
07:23

Using a Whole-mount Immunohistochemical Method to Study the Innervation of the Biliary Tract in Suncus murinus

Published on: June 15, 2017

7.2K

Related Experiment Videos

Last Updated: Feb 3, 2026

Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction
07:44

Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction

Published on: March 25, 2022

6.8K
Hepatocyte-specific Ablation in Zebrafish to Study Biliary-driven Liver Regeneration
08:14

Hepatocyte-specific Ablation in Zebrafish to Study Biliary-driven Liver Regeneration

Published on: May 20, 2015

9.1K
Using a Whole-mount Immunohistochemical Method to Study the Innervation of the Biliary Tract in Suncus murinus
07:23

Using a Whole-mount Immunohistochemical Method to Study the Innervation of the Biliary Tract in Suncus murinus

Published on: June 15, 2017

7.2K

Area of Science:

  • Autoimmune liver disease
  • Immunopathology
  • Cholangiopathies

Background:

  • Primary biliary cholangitis (PBC) is an autoimmune liver disease with a strong female predominance.
  • It is characterized by specific autoantibodies targeting mitochondrial antigens.
  • Disease progression involves cholestasis, fibrosis, and potentially cirrhosis.

Purpose of the Study:

  • To elucidate the complex pathogenesis of primary biliary cholangitis.
  • To identify key immune pathways and genetic factors involved in disease development.
  • To explore potential therapeutic targets based on current understanding.

Main Methods:

  • Review of current research on PBC pathogenesis.
  • Analysis of immune responses, including autoantibodies and cellular immunity.
  • Consideration of genetic, epigenetic, and microRNA involvement.

Main Results:

  • Anti-mitochondrial antibodies (AMAs) target pyruvate dehydrogenase complex E2 (PDC-E2) on biliary epithelial cells (BECs).
  • Breakdown of BECs' protective barrier may expose antigens, initiating an immune response.
  • Immune dysregulation, involving effector and regulatory cells, drives progressive biliary injury. Genome-wide studies highlight IL-12 pathway involvement.

Conclusions:

  • Understanding PBC pathogenesis involves recognizing AMA targets, BEC vulnerability, and immune imbalances.
  • Genetic factors (e.g., IL-12 pathway) and epigenetic mechanisms contribute to disease.
  • Further research into these pathways may lead to novel therapeutic strategies for PBC.